1. MON-454 Recovery of the Hypothalamic-Pituitary-Adrenal, Gonadal, and Thyroid Axes Following Trans-Sphenoidal Adenomectomy: A Single Center Experience
- Author
-
Sonali Gunatilake, Andrea M. Isidori, Riccardo Pofi, Jeremy W. Tomlinson, Simon Cudlip, Aparna Pal, Victoria Macgregor, and Bahram Jafar-Mohammadi
- Subjects
medicine.medical_specialty ,endocrine system ,medicine.anatomical_structure ,Endocrinology ,Neuroendocrinology and Pituitary ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal medicine ,Thyroid ,medicine ,business ,Single Center ,Trans sphenoidal - Abstract
Background Hypopituitarism is a potential sequelea of pituitary macroadenoma or trans-sphenoidal adenomectomy (TSA). Recovery of pituitary function can occur post-TSA, and reassessment is required to avoid needless hormonal replacement. The timing and frequency of re-testing is variable across centres and the aim of this study was to determine rate of, and time to recovery of hypothalamic-pituitary adrenal (HPA), gonadal and thyroid axes postTSA. Methods We performed a single-centre retrospective analysis of TSA patients from February 2015 to September 2018. Patients with apoplexy, corticotroph adenomas, redo-surgery, emergency TSA, craniotomy or pituitary radiotherapy were excluded. Thyroid, gonadal and HPA axis adequacy was respectively assessed with TSH/freeT4, FSH/LH/estradiol or testosterone measurement and short synacthen test (SST), performed pre-TSA and at 6-weeks, 3-, 6-, and 9 to 12-months post-TSA. Results Data on 135 patients (mean age 54±17 years; 80M) were analysed. Macroadenomas occurred in 118 (87.4%), microadenoma in 8 (5.9%). Histology confirmed gonadotroph (53%), somatotroph (10.4%), plurihormonal (13.3%), lactotroph (5.2%), meningioma (1.5%), craniopharyngioma (12.6%), thyrotroph (1.5%) and metastatic malignancy (2.2%). 53.7%, 30.2% and 19.1% of patients had pre-op gonadal, thyroid and HPA function deficit respectively. 59% of patients had at least one deficit at baseline. Age was associated with the number of deficits manifested (F=6.026, p6 weeks post-op.
- Published
- 2019